secwatch.observer — SEC 8-K summary
======================================

Issuer:     Annovis Bio, Inc. (ANVS)
CIK:        0001477845
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001104659-24-037958
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Annovis Bio closes $3M equity offering of 316,455 shares at $9.48/share
-----------------------------------------------------------------------

- Raised $3,000,000 gross proceeds from sale of 316,455 common shares at $9.48 per share to an institutional investor.
- Offering closed on March 22, 2024, under effective shelf registration statement on Form S-3 (No. 333-276814).
- Securities Purchase Agreement signed March 21, 2024; shares issued directly without a placement agent.
- Proceeds expected for general corporate purposes; dilution of ~3.2% based on prior outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924037958/0001104659-24-037958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477845/000110465924037958/tm249453d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-037958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer